http://www.sinomed.com/2016/08/03/personal-debt-or-company-debt-we-explore-your-options/ WebMay 19, 2024 · Conclusions: The BuMA Supreme had a faster coverage than the XIENCE at one month, presumably due to faster and shorter sirolimus elution. The difference in …
UpToDate
WebOct 20, 2024 · BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial. EuroIntervention . 2024 ; 16:e900e903. doi: 10.4244/EIJ-D-19-00566 Crossref Medline Google Scholar WebJul 23, 2024 · BuMA Supreme is the company's second-generation DES with eG Coating, biodegradable polymer and sirolimus drug. The therapeutic coating has been formulated … square roots of 2
SINOMED completes one-year follow-up of BuMA Supreme DES …
WebJan 31, 2024 · The Supreme healing-targeted drug-eluting stent (DES) is designed to promote endothelial healing to reduce stent-related adverse events. This may be particularly relevant among complex lesions that have a higher rate of adverse events. We sought to compare 1-year outcomes of percutaneous coronary intervention in complex lesions … WebMar 1, 2012 · A prospective, multicenter, randomized OCT study of early neointimal condition at first and second months after BuMA Supreme stent versus XIENCE stent implantation in high-bleeding-risk coronary artery disease patients: study protocol for a randomized controlled trial. Bo Li, Q. Jin, +7 authors Z. Yuan WebJul 23, 2024 · "BuMA Supreme proporciona un nuevo concepto interesante para los stents liberadores de fármacos con tecnología eG Coating™ y farmacocinética única que cuenta con un retorno más rápido de ... square roots of 0